Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 1/2014

01.02.2014 | Commentary

Benefits of deprescribing on patients’ adherence to medications

verfasst von: Emily Reeve, Michael D. Wiese

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Deprescribing is a holistic process of medication cessation that encompasses gaining a comprehensive medication list, identifying potentially inappropriate medications, deciding if the identified medication can be ceased, planning the withdrawal regimen and monitoring, support and follow-up. It is currently being investigated as a mechanism to reduce unnecessary or redundant medications. However, given the systematic and patient-centred nature of the deprescribing process, it is possible that it may also confer additional benefits such as improving adherence to medications, even if there is no net reduction in overall medication use. Specifically, deprescribing may improve adherence via reducing polypharmacy, reducing the financial costs associated with medication taking, increasing the patient’s medication knowledge through education, increasing patient engagement in medication management and resolution of adverse drug reactions. More research into deprescribing must be conducted to establish if these potential benefits can be realised, in addition to establishing any negative consequences.
Literatur
1.
Zurück zum Zitat Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5:345–51.PubMedCrossRef Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5:345–51.PubMedCrossRef
2.
Zurück zum Zitat Woodward M. Deprescribing : achieving better health outcomes for older people through reducing medications. J Pharm Pract Res. 2003;33:323–8. Woodward M. Deprescribing : achieving better health outcomes for older people through reducing medications. J Pharm Pract Res. 2003;33:323–8.
3.
Zurück zum Zitat Le Couteur DG, Banks E, Gnjidic D, McLachlan A. Deprescribing. Australian Prescriber. 2011;34:182–5. Le Couteur DG, Banks E, Gnjidic D, McLachlan A. Deprescribing. Australian Prescriber. 2011;34:182–5.
4.
Zurück zum Zitat Hardy JE, Hilmer SN. Deprescribing in the last year of life. J Pharm Pract Res. 2011;41:146–51. Hardy JE, Hilmer SN. Deprescribing in the last year of life. J Pharm Pract Res. 2011;41:146–51.
5.
Zurück zum Zitat Bain KT, Holmes HM, Beers MH, Maio V, Handler SM, Pauker SG. Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc. 2008;56:1946–52.PubMedCentralPubMedCrossRef Bain KT, Holmes HM, Beers MH, Maio V, Handler SM, Pauker SG. Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc. 2008;56:1946–52.PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Scott I, Gray L, Martin J, Mitchell C. Minimizing inappropriate medications in older populations: a 10-step conceptual framework. Am J Med. 2012;125:529–37.PubMedCrossRef Scott I, Gray L, Martin J, Mitchell C. Minimizing inappropriate medications in older populations: a 10-step conceptual framework. Am J Med. 2012;125:529–37.PubMedCrossRef
8.
Zurück zum Zitat Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2002;26:331–42.CrossRef Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2002;26:331–42.CrossRef
9.
Zurück zum Zitat Shoemaker SJ, de Oliveira DR. Understanding the meaning of medications for patients: the medication experience. Pharm World Sci. 2008;30:86–91.PubMedCentralPubMedCrossRef Shoemaker SJ, de Oliveira DR. Understanding the meaning of medications for patients: the medication experience. Pharm World Sci. 2008;30:86–91.PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. The Cochrane Library. 2008;2:CD000011. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. The Cochrane Library. 2008;2:CD000011.
11.
Zurück zum Zitat Barat I, Andreasen F, Damsgaard EM. Drug therapy in the elderly: what doctors believe and patients actually do. Br J Clin Pharmacol. 2001;51:615–22.PubMedCrossRef Barat I, Andreasen F, Damsgaard EM. Drug therapy in the elderly: what doctors believe and patients actually do. Br J Clin Pharmacol. 2001;51:615–22.PubMedCrossRef
12.
Zurück zum Zitat Chapman RH, Benner JS, Petrilla AA, Tierce JC, Collins R, Battleman DS, et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005;165:1147–52.PubMedCrossRef Chapman RH, Benner JS, Petrilla AA, Tierce JC, Collins R, Battleman DS, et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005;165:1147–52.PubMedCrossRef
13.
Zurück zum Zitat Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23:1296–310.PubMedCrossRef Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23:1296–310.PubMedCrossRef
14.
Zurück zum Zitat Nichols-English G, Poirier S. Optimizing adherence to pharmaceutical care plans. J Am Pharm Assoc. 2000;40:475–85. Nichols-English G, Poirier S. Optimizing adherence to pharmaceutical care plans. J Am Pharm Assoc. 2000;40:475–85.
15.
Zurück zum Zitat Dolovich L, Nair K, Sellors C, Lohfeld L, Lee A, Levine M. Do patients’ expectations influence their use of medications? Qualitative study. Can Fam Physician. 2008;54:384–93.PubMedCentralPubMed Dolovich L, Nair K, Sellors C, Lohfeld L, Lee A, Levine M. Do patients’ expectations influence their use of medications? Qualitative study. Can Fam Physician. 2008;54:384–93.PubMedCentralPubMed
16.
Zurück zum Zitat Safran DG, Neuman P, Schoen C, Montgomery JE, Li W, Wilson IB, et al. Prescription drug coverage and seniors: how well are states closing the gap? Health Aff (Millwood). 2002;21:W253–68. Safran DG, Neuman P, Schoen C, Montgomery JE, Li W, Wilson IB, et al. Prescription drug coverage and seniors: how well are states closing the gap? Health Aff (Millwood). 2002;21:W253–68.
17.
Zurück zum Zitat Reeve E, Wiese MD, Hendrix I, Roberts M, Shakib S. People’s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriatr Soc. 2013;61:1508–14.PubMedCrossRef Reeve E, Wiese MD, Hendrix I, Roberts M, Shakib S. People’s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriatr Soc. 2013;61:1508–14.PubMedCrossRef
18.
Zurück zum Zitat Williams A, Manias E, Walker R. Interventions to improve medication adherence in people with multiple chronic conditions: a systematic review. J Adv Nurs. 2008;63:132–43.PubMedCrossRef Williams A, Manias E, Walker R. Interventions to improve medication adherence in people with multiple chronic conditions: a systematic review. J Adv Nurs. 2008;63:132–43.PubMedCrossRef
19.
Zurück zum Zitat Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555–67.PubMedCrossRef Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555–67.PubMedCrossRef
20.
Zurück zum Zitat Byrne M, Walsh J, Murphy AW. Secondary prevention of coronary heart disease: patient beliefs and health-related behaviour. J Psychosom Res. 2005;58:403–15.PubMedCrossRef Byrne M, Walsh J, Murphy AW. Secondary prevention of coronary heart disease: patient beliefs and health-related behaviour. J Psychosom Res. 2005;58:403–15.PubMedCrossRef
21.
Zurück zum Zitat Conn VS, Hafdahl AR, Cooper PS, Ruppar TM, Mehr DR, Russell CL. Interventions to improve medication adherence among older adults: meta-analysis of adherence outcomes among randomized controlled trials. Gerontologist. 2009;49:447–62.PubMedCrossRef Conn VS, Hafdahl AR, Cooper PS, Ruppar TM, Mehr DR, Russell CL. Interventions to improve medication adherence among older adults: meta-analysis of adherence outcomes among randomized controlled trials. Gerontologist. 2009;49:447–62.PubMedCrossRef
22.
Zurück zum Zitat Iyer S, Naganathan V, McLachlan AJ, Le Couteur DG. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging. 2008;25:1021–31.PubMedCrossRef Iyer S, Naganathan V, McLachlan AJ, Le Couteur DG. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging. 2008;25:1021–31.PubMedCrossRef
23.
Zurück zum Zitat Hering-Hanit R, Yavetz A, Dagan Y. Effect of withdrawal of misused medication on sleep disturbances in migraine sufferers with chronic daily headache. Headache. 2000;40:809–12.PubMedCrossRef Hering-Hanit R, Yavetz A, Dagan Y. Effect of withdrawal of misused medication on sleep disturbances in migraine sufferers with chronic daily headache. Headache. 2000;40:809–12.PubMedCrossRef
24.
Zurück zum Zitat Chiatti C, Bustacchini S, Furneri G, Mantovani L, Cristiani M, Misuraca C, et al. The economic burden of inappropriate drug prescribing, lack of adherence and compliance, adverse drug events in older people. Drug Saf. 2012;35:73–87.PubMedCrossRef Chiatti C, Bustacchini S, Furneri G, Mantovani L, Cristiani M, Misuraca C, et al. The economic burden of inappropriate drug prescribing, lack of adherence and compliance, adverse drug events in older people. Drug Saf. 2012;35:73–87.PubMedCrossRef
25.
Zurück zum Zitat Donovan J, Blake D, Fleming W. The patient is not a blank sheet: lay beliefs and their relevance to patient education. Rheumatology. 1989;28:58–61.CrossRef Donovan J, Blake D, Fleming W. The patient is not a blank sheet: lay beliefs and their relevance to patient education. Rheumatology. 1989;28:58–61.CrossRef
26.
Zurück zum Zitat Beer C, Pk Loh, Peng YG, Potter K, Millar A. A pilot randomized controlled trial of deprescribing. Ther Adv Drug Saf. 2011;2:37–43.CrossRef Beer C, Pk Loh, Peng YG, Potter K, Millar A. A pilot randomized controlled trial of deprescribing. Ther Adv Drug Saf. 2011;2:37–43.CrossRef
27.
Zurück zum Zitat Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med. 2010;170:1648–54.PubMedCrossRef Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med. 2010;170:1648–54.PubMedCrossRef
28.
Zurück zum Zitat Williams M, Pulliam C, Hunter R, Johnson T, Owens J, Kincaid J, et al. The short-term effect of interdisciplinary medication review on function and cost in ambulatory elderly people. J Am Geriatr Soc. 2004;52:93–8.PubMedCrossRef Williams M, Pulliam C, Hunter R, Johnson T, Owens J, Kincaid J, et al. The short-term effect of interdisciplinary medication review on function and cost in ambulatory elderly people. J Am Geriatr Soc. 2004;52:93–8.PubMedCrossRef
29.
Zurück zum Zitat Hilmer SN, Gnjidic D, Le Couteur DG. Thinking through the medication list-Appropriate prescribing and deprescribing in robust and frail older patients. Aust Fam Physician. 2012;41:924.PubMed Hilmer SN, Gnjidic D, Le Couteur DG. Thinking through the medication list-Appropriate prescribing and deprescribing in robust and frail older patients. Aust Fam Physician. 2012;41:924.PubMed
30.
Zurück zum Zitat Chodosh J, Morton SC, Mojica W, Maglione M, Suttorp MJ, Hilton L, et al. Meta-analysis: chronic disease self-management programs for older adults. Ann Intern Med. 2005;143:427–38.PubMedCrossRef Chodosh J, Morton SC, Mojica W, Maglione M, Suttorp MJ, Hilton L, et al. Meta-analysis: chronic disease self-management programs for older adults. Ann Intern Med. 2005;143:427–38.PubMedCrossRef
31.
Zurück zum Zitat Nguyen GC, LaVeist TA, Harris ML, Datta LW, Bayless TM, Brant SR. Patient trust in physician and race are predictors of adherence to medical management in inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:1233–9.PubMedCentralPubMedCrossRef Nguyen GC, LaVeist TA, Harris ML, Datta LW, Bayless TM, Brant SR. Patient trust in physician and race are predictors of adherence to medical management in inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:1233–9.PubMedCentralPubMedCrossRef
32.
Zurück zum Zitat Lee YY, Lin JL. The effects of trust in physician on self-efficacy, adherence and diabetes outcomes. Soc Sci Med. 2009;68:1060–8.PubMedCrossRef Lee YY, Lin JL. The effects of trust in physician on self-efficacy, adherence and diabetes outcomes. Soc Sci Med. 2009;68:1060–8.PubMedCrossRef
Metadaten
Titel
Benefits of deprescribing on patients’ adherence to medications
verfasst von
Emily Reeve
Michael D. Wiese
Publikationsdatum
01.02.2014
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 1/2014
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-013-9871-z

Weitere Artikel der Ausgabe 1/2014

International Journal of Clinical Pharmacy 1/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.